Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|April 8, 2010
Vinblastine induces acute, cell cycle phase-independent apoptosis in some leukemias and lymphomas and can induce acute apoptosis in others when Mcl-1 is suppressedBethany L Salerni, Darcy J Bates, Tina C Albershardt, et al.
Blood Cells, Molecules & Diseases|October 24, 2006
The effects of lead and cadmium on GATA-1 regulated erythroid gene expressionR Mitchell Ermentrout, Michael E Layon, Catherine J Ackley, et al.
Blood|April 26, 2007
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylationRodwell Mabaera, Christine A Richardson, Kristin Johnson, et al.
Thrombosis Research|June 8, 2018
Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort studyWalid Saliba, Amir Warwar, Antonio Kotler, et al.
International Journal of Medical Sciences|August 6, 2025
Efficacy and safety of direct oral anticoagulants in patients with venous thrombosis and inherited thrombophiliaAmir Warwar, Iren Zargari, Nili Stein, et al.
Blood|October 6, 2007
Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobinRodwell Mabaera, Michael R Greene, Christine A Richardson, et al.
Experimental Hematology|May 23, 2009
Complex developmental patterns of histone modifications associated with the human beta-globin switch in primary cellsMei Hsu, Christine A Richardson, Emmanuel Olivier, et al.
Scientific Reports|November 23, 2025
Assessing the correlation between patient and family reported outcome measures and multiple myeloma clinical parametersMouna Ballan-Haj, Kareem Midlej, Barbara Silverman, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutationSharon Alroy, Meir Preis, Menashe Barzilai, et al.
JCO Oncology Practice|August 1, 2025
Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled TrialAreen Khateeb Alabbasi, Manfred S Green, Shuli Brammli-Greenberg, et al.
Pageof 7